Abstract
Hamamoto et al were able to demonstrate that combination therapy of a lung tumor by using radiofrequency ablation with local injection of an immunostimulant, OK-432, resulted in improved survival when compared with other therapies tested in a VX2 rabbit model.

This publication has 11 references indexed in Scilit: